Early Antibiotics for Sepsis and Septic Shock: A Gold Standard

Similar documents
Sepsis. ...striking a balance. Dr Ron Daniels.

Combination vs Monotherapy for Gram Negative Septic Shock

DOES TIMING OF ANTIBIOTICS IMPACT OUTCOME IN SEPSIS? Saravana Kumar MD HEAD,DEPT OF EM,DR MEHTA S HOSPITALS CHENNAI,INDIA

Antimicrobial Therapy for Life-threatening Infections: Speed is Life

Ithas been estimated that one

La sepsi Il ruolo dell antibiotico terapia

Welcome! 10/26/2015 1

AND MISCONCEPTIONS IN THE MANAGEMENT OF SEPSIS

Appropriate antimicrobial therapy in HAP: What does this mean?

10 Golden rules of Antibiotic Stewardship in ICU. Jeroen Schouten, MD PhD intensivist, Nijmegen (Neth) Istanbul, Oct 6th 2017

Antimicrobial stewardship in managing septic patients

Antibiotic treatment in the ICU 1. ICU Fellowship Training Radboudumc

Antibiotic usage in nosocomial infections in hospitals. Dr. Birgit Ross Hospital Hygiene University Hospital Essen

Taiwan Crit. Care Med.2009;10: %

Mono- versus Bitherapy for Management of HAP/VAP in the ICU

Does Early and Appropriate Antibiotic Administration Improve Mortality in Emergency Department Patients with Severe Sepsis or Septic Shock?

Reducing the Burden of Severe Sepsis and Infections in Indian ICUs

Appropriate Antibiotic Administration in Critically Ill Patients with Pneumonia

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

Maximizing the efficacy of antibiotic therapy

Antimicrobial therapy in critical care

ESISTONO LE HCAP? Francesco Blasi. Sezione Medicina Respiratoria Dipartimento Toraco Polmonare e Cardiocircolatorio Università degli Studi di Milano

NUOVE IPOTESI e MODELLI di STEWARDSHIP

Nosocomial Infections: What Are the Unmet Needs

Epidemiology of early-onset bloodstream infection and implications for treatment

Trea%ng Sepsis in 2016 Are the Big Guns Losing the War?

FOLLOWING BUNDLE ADMINISTERED WITHIN ONE HOUR.

Comparative Clinical Evaluation of the T2Bacteria Panel versus Blood Culture for the Diagnosis of Bacteremia

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

NIH Public Access Author Manuscript Crit Care Med. Author manuscript; available in PMC 2012 September 1.

Linda Taggart MD FRCPC Infectious Diseases Physician Lead Physician, Antimicrobial Stewardship Program St. Michael s Hospital

Antimicrobial Cycling. Donald E Low University of Toronto

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

Optimize Durations of Antimicrobial Therapy

Procalcitonin to Predict Septic Shock & Guide Antibiotic Therapy

Konsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program

Sustaining an Antimicrobial Stewardship

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018

Get Smart For Healthcare

Antibiotic Stewardship in the Hospital Setting

Maximizing the efficacy of antibiotic therapy

Dr. Shaiful Azam Sazzad. MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College

Multi-drug resistant microorganisms

Why we perform susceptibility testing

Successful stewardship in hospital settings

Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial

MANAGING ANTIBIOTIC THERAPY

The Use of Procalcitonin to Improve Antibiotic Stewardship

Rifat S. Rehmani, 1 Javed I. Memon, 2 and Ayman Al-Gammal Background

Antibiotic stewardship in long term care

Development of Drugs for HAP-VAP. Robert Fromtling, MD

OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS

Critical Appraisal Topic. Antibiotic Duration in Acute Otitis Media in Children. Carissa Schatz, BSN, RN, FNP-s. University of Mary

Bacterial infections complicating cirrhosis

Key words: antibiotics; intensive care; mechanical ventilation; outcomes; pneumonia; resistance

Scottish Medicines Consortium

Duration of antibiotic therapy:

Antibacterials. Recent data on linezolid and daptomycin

The importance of infection control in the era of multi drug resistance

Antibacterial Resistance: Research Efforts. Henry F. Chambers, MD Professor of Medicine University of California San Francisco

Collecting and Interpreting Stewardship Data: Breakout Session

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012

Disclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials

Antibiotics and Duration

Health Informatics Centre, Division of Community Health Sciences, Dundee, UK

The surgical site infection risk in developing countries. Yves BUISSON Société de Pathologie Exotique

de Groot et al. Critical Care (2015) 19:194 DOI /s

The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens

Why should we care about multi-resistant bacteria? Clinical impact and

Meropenem for all? Midge Asogan ICU Fellow (also ID AT)

Learning Points. Raymond Blum, M.D. Antimicrobial resistance among gram-negative pathogens is increasing

Global Status of Antimicrobial Resistance with a Focus on Nepal

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

Active Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

Received 23 May 2004/Returned for modification 31 August 2004/Accepted 11 October 2004

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

ICU Volume 14 - Issue 4 - Winter 2014/ Matrix

Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland

Antimicrobial Stewardship

College of Medicine, Chang Gung University, Taoyuan, Taiwan. Abstract

Study Protocol. Funding: German Center for Infection Research (TTU-HAARBI, Research Clinical Unit)

Fighting MDR Pathogens in the ICU

Antibiotic Stewardship. Matthew Dryden MD Hampshire Hospitals, Southampton University

Role of the general physician in the management of sepsis and antibiotic stewardship

Septicaemia Definitions 1

Sepsis is the most common cause of death in

Objectives. Basic Microbiology. Patient related. Environment related. Organism related 10/12/2017

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Central Nervous System Infections

Pharmacokinetics and Pharmacodynamics of Antimicrobials in the Critically Ill Patient

Rational management of community acquired infections

Appropriate Antimicrobial Therapy for Treatment of

Drug-resistant TB therapy: the future is now

Healthcare-Associated Pneumonia and Community-Acquired Pneumonia: ACCEPTED. A Single Center Experience. Scott T. Micek, PharmD 1

ORIGINAL INVESTIGATION. Associations Between Initial Antimicrobial Therapy and Medical Outcomes for Hospitalized Elderly Patients With Pneumonia

Methicillin-Resistant Staphylococcus aureus Nasal Swabs as a Tool in Antimicrobial Stewardship

Burden of disease of antibiotic resistance The example of MRSA. Eva Melander Clinical Microbiology, Lund University Hospital

Transcription:

Early Antibiotics for Sepsis and Septic Shock: A Gold Standard Anand Kumar MD, FRCPC, FCCP, FCCM Professor of Medicine University of Manitoba Health Sciences Centre St. Boniface Hospital Winnipeg, Manitoba For available slides: search anand kumar medicine manitoba Email: akumar61@yahoo.com `

Surviving Sepsis Bundle 2012 Severe Sepsis 3-Hour Resuscitation Bundle administer broad spectrum antimicrobials (1 hr) lactate level blood cultures prior to administration of antimicrobials 30 ml/kg crystalloid for hypotension or lactate 4 mmol/l

The Gold Standard for Evidence in Medical Science RCT? Generalizability Reproducibility! Glycemic control Physiologic corticosteroid therapy Activated protein C (drotrecogin-alfa) Goal-directed resuscitation 3

The Gold Standard for Evidence in Biological Science Biologic rationale a reasonable hypothesis Reproducibility across a wide range of study designs including observational studies; in the case of early antimicrobials Experimental animal studies Direct observational human data Indirect but related observational data Bundle analysis 4

Speed is Life The speed of clearance of the microbial pathogen is the critical determinant of outcome in septic shock (and other conditions where there is a timedependent risk of irreversible and irreplaceable organ failure) 5

Sepsis and Septic Shock: An Intensivist s Immunologic View Antimicrobials Infection CARS SIRS Organ Injury Antiinflammatory (endogenous) Time RECOVERY van der Poll T, van Deventer SJH. Infect Dis Clin N Am 6

An Injury Paradigm of Septic Shock: The Golden Hours A Kumar, Virulence 2014;5:80 97 Cellular dysfunction/tissue injury DEATH Inflammatory response Toxic burden Shock Threshold Microbial load TIME 7

An Injury Paradigm of Sepsis and Septic Shock earlier antimicrobial therapy Cellular dysfunction/tissue injury Shock Threshold Microbial load Inflammatory response Toxic burden A Kumar, Virulence 2014;5:80 97 TIME 8

% survival E. coli murine peritonitis/septic shock mortality vs time of antibiotic initiation 100 1500 cfu 80 60 40 20 0 sham (n=20) no Rx (n=20) saline (n=10) Ab Rx 0h (n=10) Ab Rx 6h (n=10) Ab Rx 12h (n=10) Ab Rx 15h (n=10) Ab Rx 18h (n=10) time response p<.0001 0 6 12 18 24 30 36 42 48 54 60 66 72 78 84 90 96 Kumar et al, JID 2006 hrs post-implant 9

MAP (mm Hg) Mean Arterial Pressure in Murine 120 Septic Shock 100 80 * 60 40 P < 0.0001 20 0 12 24 36 48 60 72 84 96 Time (hr) Kumar et al, JID 2006 10

Cumulative Initiation of Effective Antimicrobial Therapy and Survival in Septic Shock fraction of total patients 1.0 survival fraction cumulative antibiotic initiation 0.8 0.6 0.4 0.2 0.0 Kumar et al. CCM. 2006:34:1589-96. time from hypotension onset (hrs) 11

Odds Ratio of Death (95% Confidence Interval) Mortality Risk with Increasing Delays in Initiation of Effective Antimicrobial Therapy 100 10 1 Kumar et al, CCM. 2006:34:1589-96. Time (hrs) 12

Hospital Mortality Time to Antimicrobial: Severe Sepsis Ferrer et al, Crit Care Med 2014;42:1749-1755

Benefit of Early versus Late Antibiotics Author Year N Diagnosis Miner 2001 171 Meningitis Larche 2002 88 Bact/pneumonia* Houck 2004 13,771 Pneumonia Proulx 2005 118 Meningitis Meehan 1997 14,069 Pneumonia Gacouin 2002 213 Legionella Iregui 2006 107 VAP Lodise 2003 167 S. aureus Kang 2003 123 P. aeruginosa * courtesy, C Natanson 0.01 0.1 1 10 100 Harm Benefit Odds Ratio of Survival (95% CI)

Impact of Appropriateness of Initial Antimicrobial Therapy on Survival from Septic Shock all culture + culture - bacteremia + bacteremia - community nosocomial pneu IAI sst uti cri all culture + culture - bacteremia + bacteremia - community nosocomial pneu IAI sst uti cri inappropriate appropriate lcbi %survival % appropriate 0 20 40 60 80 100 0 10 20 30 40 50 60 70 80 percent (%) survival (%) Kumar et al, Chest 2009; 136:1237 1248 lcbi 15

Metaanalysis: IAA in severe infection Paul AAC 2010;54: 4851 4863 OR Death 16

CAP Septic Shock: Finnsepsis Varpula et al, Acta Anesthesiol Scand 2007 17

Impact of Bundle Elements on Mortality of Septic Shock p value 0-1 hr.008 1-3 hr.127 3-6 hr.419 prev AbRx.383 fluid challenge.966 low dose steroid.688 apc.004.25 1 Hazard Ratio 4 Ferrer et al, AJRCCM 2009;180:861-6 18

Author/Yr Rivers 01 Trzeciak '06 Kortgen '06 Shapiro '06 Micek '06 Nguyen '07 Jones '07 El Solh 08 Studies of Severe Sepsis Bundles Survival Overall Odds Ratio of Survival (95% CI) p < 0.0001 Heterogeneity I 2 = 0%, p = 0.97 0.01 0.1 1 10 100 Favors Control Favors Bundle Barochia, et al. Crit Care Med. 2010 Vol. 38, No. 2

Studies of Severe Sepsis Bundles (what changes?): Hours to Antibiotics Author/Yr Rivers 01 Trzeciak '06 Kortgen '06 Shapiro '06 Micek '06 Nguyen '07 Jones '07 El Solh 08 3 2 1 0-1 -2 p < 0.0001 Favors Control Favors Bundle Weighted Mean Difference (± 95% CI) -3 Heterogeneity I 2 = 0%, p = 0.89 Barochia, et al. Crit Care Med. 2010 Vol. 38, No. 2

0.0001 0.001 0.01 0.1 10 100 1000 10000 Studies of Severe Sepsis Bundles Resuscitation Components (what changes?) Author / Year Rivers 01 Trzeciak '06 Kortgen '06 Shapiro '06 Micek '06 Nguyen '07 Jones '07 El Solh 08 Rivers 01 Trzeciak '06 Kortgen '06 Shapiro '06 Micek '06 Nguyen '07 Jones '07 El Solh 08 Barochia, et al. Crit Care Med. 2010 Vol. 38, No. 2 Crystalloid Usage (L) Overall not reportable -4-2 0 2 4 Inotropes I 2 = 89% p < 0.0001 I 2 = 0% p = 0.57 p = 0.0005 0.001 0.01 0.1 1 10 100 1000 Favors Control Favors Bundle Vasopressor Usage Overall not reportable 1 RBC Overall not reportable I 2 = 84% p < 0.0001 I 2 = 89% p <.0001 0.001 0.01 0.1 1 10 100 1000 Favors Control Favors Bundle

Time to Antimicrobial in Sepsis/Septic Shock: Sterling Meta-analysis Sterling et al, Crit Care Med, 2015:43:1907-1915 22

the purgamentum init, exit purgamentum problem Sterling et al, Crit Care Med, 2015:43:1907-1915 23

Requirements for an appropriate time to antimicrobial study 1. Plausible biologic rationale 2. Index to appropriate antimicrobial Systematic bias to null 3. Index to an appropriate clinical start-point Physiologic parameter vs administrative Inclusion of patients with unclear start-point (systematic bias to null) 24

Time to Antimicrobial: Severe Sepsis 100% 75% Mortality and Timing of Appropriate Antibiotic Therapy 100% 100% 86% 81% 70% 50% 25% 25% 19% 0% 0-1 1.1-2 2.1-6 6.1-12 12.1-24 24.1-48 48.1-72 Timing with respect to dose of 1st appropriate antibiotic (hours) Kumar et al. July 2003 Septic Shock data set 25

Early Antimicrobials in Sepsis and Septic Shock: The Gold Standard 26